Fringe Benefit Group
|
New York City District Council of Carpenters Benefit Funds
|
Defined Contribution Account Manager Nova 401(k) Associates
|
TPA Retirement Plan Consultant EPIC RPS (TPA/DPS)
|
Greenline Wealth Management
|
Pollard & Associates
|
Defined Benefit Consultant/Enrolled Actuary Pension Plan Specialists, PC
|
Great Lakes Pension Associates, Inc.
|
Senior Specialist 401k Recordkeeping T Bank N.A.
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
Defined Contributions Compliance Consultant Loren D. Stark Company (LDSCO)
|
Retirement Solutions Specialists
|
Retirement Planners and Administrators (RPA)
|
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Key Takeaways from Pharma Testimony at Senate Drug Pricing Hearing
HealthLeaders Media Feb. 27, 2019
"Pharmaceutical executives were questioned by lawmakers about why they have not effectively reduced list prices for prescription drugs. While acknowledging room for improvement, the executives also blamed PBMs and insurers for the high prices consumers face. Industry watchers said that while substantive change is unlikely in the short-term, the public impression of Tuesday's hearing will linger negatively on drugmakers."
|
Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |